Impact Factor 3.678

The world's most-cited Plant Sciences journal

Review ARTICLE

Front. Plant Sci., 04 February 2016 | https://doi.org/10.3389/fpls.2016.00019

Cannabis sativa: The Plant of the Thousand and One Molecules

  • Environmental Research and Innovation, Luxembourg Institute of Science and Technology, Esch-sur-Alzette, Luxembourg

Cannabis sativa L. is an important herbaceous species originating from Central Asia, which has been used in folk medicine and as a source of textile fiber since the dawn of times. This fast-growing plant has recently seen a resurgence of interest because of its multi-purpose applications: it is indeed a treasure trove of phytochemicals and a rich source of both cellulosic and woody fibers. Equally highly interested in this plant are the pharmaceutical and construction sectors, since its metabolites show potent bioactivities on human health and its outer and inner stem tissues can be used to make bioplastics and concrete-like material, respectively. In this review, the rich spectrum of hemp phytochemicals is discussed by putting a special emphasis on molecules of industrial interest, including cannabinoids, terpenes and phenolic compounds, and their biosynthetic routes. Cannabinoids represent the most studied group of compounds, mainly due to their wide range of pharmaceutical effects in humans, including psychotropic activities. The therapeutic and commercial interests of some terpenes and phenolic compounds, and in particular stilbenoids and lignans, are also highlighted in view of the most recent literature data. Biotechnological avenues to enhance the production and bioactivity of hemp secondary metabolites are proposed by discussing the power of plant genetic engineering and tissue culture. In particular two systems are reviewed, i.e., cell suspension and hairy root cultures. Additionally, an entire section is devoted to hemp trichomes, in the light of their importance as phytochemical factories. Ultimately, prospects on the benefits linked to the use of the -omics technologies, such as metabolomics and transcriptomics to speed up the identification and the large-scale production of lead agents from bioengineered Cannabis cell culture, are presented.

Introduction

The current climatic and economic scenario pushes toward the use of sustainable resources to reduce our dependence on petrochemicals and to minimize the impact on the environment. Plants are precious natural resources, because they can supply both phytochemicals and lignocellulosic biomass. In this review, we focus on hemp (Cannabis sativa L.), since it is a source of fibers, oil and molecules and as such it is an emblematic example of a multi-purpose crop. We treat the aspects related to the use of hemp biomass and, more extensively, those linked to its wide variety of phytochemicals.

Known since the ancient times for its medicinal and textile uses (Russo et al., 2008; Skoglund et al., 2013), hemp is currently witnessing a revival, because of its rich repertoire of phytochemicals, its fibers and its agricultural features, namely quite good resistance to drought and pests, well-developed root system preventing soil erosion, lower water requirement with respect to other crops, e.g., cotton. This shows the great versatility of this fiber crop and encourages future studies focused on both Cannabis (bio)chemistry and genetic engineering. Hemp varieties producing oil, biomass or even both are currently cultivated and the availability of the hemp genome sequence greatly helps molecular studies on this important crop (van Bakel et al., 2011). In addition, the scientific community is very much interested in harnessing Cannabis pharmacological power: for example microorganisms are being engineered to produce Δ9-tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA) (Taura et al., 2007a; Zirpel et al., 2015).

The final scope of this review is to discuss the potential of hemp for industry and to highlight its importance for the bio-economy. More specifically, we: (i) describe the use of hemp biomass (i.e., the fibers), (ii) discuss hemp molecules of industrial interest (namely cannabinoids, terpenes and phenolic compounds), (iii) describe the potential of hemp trichomes as pharma-factories and (iv) discuss the potential of genetic engineering, by describing the use of plant cell suspension and hairy root cultures.

Hemp Stem: A Source of Fibers with Antibacterial Properties

Plant lignocellulosic biomass is an abundant renewable resource, which can provide biopolymers, fibers, chemicals and energy (Guerriero et al., 2014, 2015, 2016). Trees are important for the provision of wood, however, also fast-growing herbaceous species, like textile hemp (which has a THC content <0.3%; Weiblen et al., 2015), can provide high biomass quantities in a short time. The stem of this fiber crop supplies both cellulosic and woody fibers: the core is indeed lignified, while the cortex harbors long cellulose-rich fibers, known as bast fibers (Figure 1) (Guerriero et al., 2013).

FIGURE 1
www.frontiersin.org

FIGURE 1. Anatomical details of Cannabis stem. (A) Stem of an adult plant (ca 2 months); (B) The stem can be peeled off and shows a lignified core and a cortex with bast fibers. (C) Longitudinal section of hemp stem stained with toluidine blue showing the cortex with a bundle of bast-fibers (white asterisk) and the core with xylem vessels (black asterisk).

This heterogeneous cell wall composition makes hemp stem an interesting model to study secondary cell wall biosynthesis, in particular the molecular events underlying the deposition of cortical gelatinous bast fibers and core woody fibers.

Cannabis woody fibers (a.k.a “hurds” or “shivs”) are used for animal bedding because of their high absorption capacity and for the creation of a concrete-like material.

Hemp bast fibers are used in the biocomposite sector as a substitute of glass fibers. The automotive industry is particularly keen on using hemp bast fibers to produce bioplastics: this material is stronger than polypropylene plastic and lighter in weight (Marsh, 2003).

Beyond the applications in the construction and automotive industries, hemp fibers are attractive also in the light of their natural antibacterial property. Hemp bast fibers have been indeed described as antibacterial (Hao et al., 2014; Khan et al., 2015) and their use for the manufacture of an antibacterial finishing agent (Bao et al., 2014), surgical devices (Gu, 2006) or functionalized textiles (Cassano et al., 2013) has been reported. This property is linked to the chemical composition of hemp bast fibers: both free and esterified sterols and triterpenes have been identified, among which β-sitosterol and β-amyrin (Gutiérrez and del Río, 2005). These compounds possess known antibacterial properties (Kiprono et al., 2000; Ibrahim, 2012). Hemp bast fibers were also found to contain cannabinoids (2% of the total metabolite extract) (Bouloc et al., 2013 and references therein). More recently hemp hurd powder showed antibacterial properties against Escherichia coli (Khan et al., 2015). Since the hurd has a higher lignin content than the bast fibers, its antibacterial property may be linked to lignin-related compounds such phenolic compounds, as well as alkaloids and cannabinoids (Appendino et al., 2008; Khan et al., 2015).

Hemp Phytochemicals: Their Production Pathways and Myriad of Biological Activities

Numerous chemicals are produced in hemp through the secondary metabolism. They include cannabinoids, terpenes and phenolic compounds (Flores-Sanchez and Verpoorte, 2008) and will be further described in the next sections. Although the pharmacological properties of cannabinoids have extensively been studied and are the most recognized hemp bioactives, the other components have no reasons to envy them, as they have also been associated with potent health-promoting properties. Research on Cannabis phytochemicals, as well as the widespread therapeutic use of Cannabis products, has been limited due to various reasons, including illegality of cultivation (due to its psychoactivity and potential for inducing dependence), variability of active components, and low abundance of some of them in planta. Further attentions is now drawn toward non-THC Cannabis active components, which may act synergistically and contribute to the pharmacological power and entourage effects of medicinal-based Cannabis extract (Russo, 2011).

Phytocannabinoids

Phytocannabinoids represent a group of C21 or C22 (for the carboxylated forms) terpenophenolic compounds predominantly produced in Cannabis. They have also been reported in plants from the Radula and Helichrysum genus (Appendino et al., 2008) but our knowledge on non-Cannabis source of cannabinoids is still in its infancy (Gertsch et al., 2010). More than 90 different cannabinoids have been reported in the literature, although some of these are breakdown products (ElSohly and Slade, 2005; Brenneisen, 2007; Radwan et al., 2009; Fischedick et al., 2010) and they are generally classified into 10 subclasses (Brenneisen, 2007). In this review, we will focus on the most abundant compounds found in the drug- and fiber-type Cannabis. The predominant compounds are THCA, CBDA and cannabinolic acid (CBNA), followed by cannabigerolic acid (CBGA), cannabichromenic acid (CBCA) and cannabinodiolic acid (CBNDA) (ElSohly and Slade, 2005). THCA is the major cannabinoid in the drug-type Cannabis, while CBDA predominates in fiber-type hemps. CBCA has been reported to dominate in the cannabinoid fraction of young plants and to decline with maturation (Meijer et al., 2009). The phytocannabinoid acids are non-enzymatically decarboxylated into their corresponding neutral forms, which occur both within the plant and, to a much larger extent, upon heating after harvesting (Flores-Sanchez and Verpoorte, 2008). Phytocannabinoids accumulate in the secretory cavity of the glandular trichomes, which largely occur in female flowers and in most aerial parts of the plants, as further described in the next section. They have also been detected in low quantity in other parts of the plants including the seeds (Ross et al., 2000), roots (Stout et al., 2012) and the pollen (Ross et al., 2005), in an extent depending on the drug- or fiber-type of Cannabis, as described in Table 1. More generally, the concentration of these compounds depends on tissue type (Table 1), age, variety, growth conditions (nutrition, humidity, light level), harvest time and storage conditions (Khan et al., 2014). The level of phytocannabinoids in hempseeds, and thereby of hempseed oil, should be very low as the kernel contains only trace amount of THC or CBD (Leizer et al., 2000; Ross et al., 2000). However, higher THC concentrations are found on the outside surface of the seed coat, possibly as the result of contamination with plant leaves or flowers (Ross et al., 2000). Recently, significant amounts of cannabinoids, and particularly of THC, were found in five out of 11 hempseed oil samples available on the Croatian market, suggesting that both contaminations are due to improper processing procedures and the illegal use of drug-type hemp (with a THC + CBN/CBD ratio >1) for nutritional purposes (Petrović et al., 2015). Cannabinoids in the leaves have been shown to decrease with the age and along the stem axis, with the highest levels observed in the leaves of the uppermost nodes (Pacifico et al., 2008). Cannabinoid contents in the stem are scarce in the literature. An analysis performed on the dust obtained from the top section of the stem of fiber-type hemp (low percentage of bast fibers) revealed a low THC and CBD content (0.04 and 1.3% on average, respectively) (Cappelletto et al., 2001). Kortekaas et al. (1995) analyzed the cannabinoid content of hemp black liquor. The sum of the THC and CBD fractions (without reporting the distinct amounts of each of them) in hemp stem wood and bark extractives was 2 and 1%, respectively, which represented 0.003 and 0.0005% of the total fiber content.

TABLE 1
www.frontiersin.org

TABLE 1. Summary of the concentrations in cannabinoids found in different parts of the hemp plants, in vitro hairy roots, and some commercial medicinal products.

Biosynthetic Pathway Leading to Phytocannabinoids

The biosynthesis of cannabinoids from C. sativa has only been recently elucidated. The precursors of cannabinoids actually originate from two distinct biosynthetic pathways: the polyketide pathway, giving rise to olivetolic acid (OLA) and the plastidal 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway, leading to the synthesis of geranyl diphosphate (GPP) (Sirikantaramas et al., 2007) (Figure 2). OLA is formed from hexanoyl-CoA, derived from the short-chain fatty acid hexanoate (Stout et al., 2012), by aldol condensation with three molecule of malonyl-CoA. This reaction is catalyzed by a recently discovered polyketide synthase (PKS) enzyme and an olivetolic acid cyclase (OAC) (Gagne et al., 2012). The geranylpyrophosphate:olivetolate geranyltransferase catalyzes the alkylation of OLA with GPP leading to the formation of CBGA, the central precursor of various cannabinoids (Fellermeier and Zenk, 1998). Three oxidocyclases will then be responsible for the diversity of cannabinoids: the THCA synthase (THCAS) converts CBGA to THCA, while CBDA synthase (CBDAS) forms CBDA and CBCA synthase (CBCAS) produces CBCA (Sirikantaramas et al., 2004, 2005; Taura et al., 2007b). Propyl cannabinoids (cannabinoids with a C3 side-chain, instead of a C5 side-chain), such as tetrahydrocannabivarinic acid (THCVA), synthetized from a divarinolic acid precursor, have also been reported in Cannabis (Flores-Sanchez and Verpoorte, 2008).

FIGURE 2
www.frontiersin.org

FIGURE 2. Schematic view of the biosynthetic pathways leading to the Cannabis secondary metabolites discussed in this review. Transport of precursors is represented by dashed arrows, while direct catalytic reactions are depicted by bold arrows. See text for detailed pathways. Abbreviations used: IPP, isopentenyl diphosphate; DMAPP, dimethylallyl diphosphate; GPP, geranyl diphosphate; FPP, farnesyl diphosphate; MVA, mevalonate; MEP, methylerythritol phosphate.

Health Benefits Linked to Cannabinoids

The pharmacology of phytocannabinoids has previously been reviewed elsewhere (Pacher et al., 2006; Russo, 2011; Hill et al., 2012; Giacoppo et al., 2014; Burstein, 2015) and a brief summary and update will be presented hereafter.

Most of the biological properties related to cannabinoids rely on their interactions with the endocannabinoid system in humans. The endocannabinoid system includes two G protein-coupled cannabinoid receptors, CB1 and CB2, as well as two endogenous ligands, anandamide and 2-arachidonylglycerol. Endocannabinoids are thought to modulate or play a regulatory role in a variety of physiological processing including appetite, pain-sensation, mood, memory, inflammation, insulin, sensitivity and fat and energy metabolism (De Petrocellis et al., 2011; Di Marzo and Piscitelli, 2015). The psychoactive decarboxylated form of THCA, THC, is a partial agonist of both CB1 and CB2 receptors, but has higher affinity for the CB1 receptor, which appears to mediate its psychoactive properties. In addition to being present in the central nervous system and throughout the brain, CB1 receptors are also found in the immune cells and the gastrointestinal, reproductive, adrenal, heart, lung and bladder tissues, where cannabinoids can therefore also exert their activities. CB2 receptors are thought to have immunomodulatory effects and to regulate cytokine activity. But THC has actually more molecular targets than just CB1 and CB2 receptors, and exhibit potent anti-inflammatory, anti-cancer, analgesic, muscle relaxant, neuro-antioxidative (De Petrocellis et al., 2011), and anti-spasmodic activities (Pacher et al., 2006). However, THC has been also associated with a number of side effects, including anxiety, cholinergic deficits, and immunosuppression (Russo, 2011). CBDA is the most prevalent phytocannabinoid in the fiber-type hemp, and the second most important in the drug chemotypes. CBD (decarboxylation of CBDA) presents a large array of pharmacological properties, as recently reviewed in Burstein (2015), which has been downplayed for many years, as compared to THC. CBD acts yet as an important entourage compound as it is able to reduce the side effects of THC (Englund et al., 2012), and may thereby increase the safety of Cannabis-based extracts. CBD itself has been shown in in vitro and animal studies to possess, among others, anti-anxiety, anti-nausea, anti-arthritic, anti-psychotic, anti-inflammatory, and immunomodulatory properties (Burstein, 2015). CBD is a very promising cannabinoid as it has also shown potential as therapeutic agents in preclinical models of central nervous system diseases such as epilepsy, neurodegenerative diseases, schizophrenia, multiple sclerosis, affective disorders and the central modulation of feeding behavior (Hill et al., 2012). Interestingly, CBD presents also strong anti-fungal and anti-bacterial properties, and more interestingly powerful activity against methicillin-resistant Staphylococcus aureus (MRSA) (Appendino et al., 2008). After THC and CBD, CBC is the third most prevalent phytocannabinoid. CBC presents notably anti-inflammatory (Delong et al., 2010), sedative, analgesic (Davis and Hatoum, 1983), anti-bacterial and antifungal properties (Eisohly et al., 1982). CBC is also a potent inhibitor of anandamide uptake, an endogenous ligand of CB receptors (De Petrocellis et al., 2011). CBN is a degradation product of THC and is mostly found in aged Cannabis. CBN has a twofold lower affinity for CB1 receptors and a threefold higher affinity for the CB2 receptors, as compared to THC. It thus affects cells of the immune system more than the central nervous system, as reviewed in (McPartland and Russo, 2001). Current cannabinoid-based therapeutic treatments is limited to special cases, i.e., spasticity associated to multiple sclerosis in adult patients, to treat nausea/vomiting linked to cancer therapies, to stimulate appetite in HIV-positive patients (Giacoppo et al., 2014; Lynch and Ware, 2015). Borrelli et al. (2013), after highlighting the beneficial effects of CBG on murine colitis, suggest that this cannabinoid should also be considered for clinical experimentation in patients affected by inflammatory bowel disease.

Adverse Health Effects of Cannabinoids

As mentioned earlier, the recreational and medical use of Cannabis as well as of THC and other synthetic cannabinoids have also been associated with numerous side effects. Two recent reviews (Volkow et al., 2014; van Amsterdam et al., 2015) notably reported the adverse health effects linked to the use of natural Cannabis and synthetic cannabinoids, respectively. When adjusted for confounders such as cigarette smoking, the impact of short- and long-term use appear to be similar for both types of consumption and are directly linked to the level of THC or its synthetic analog. The THC content of recreational Cannabis has indeed drastically increased in the last 30 years (from 3% in 1980s to almost 20% now, as reported in Table 1), with very low level of the other cannabinoids such as CBD. Effects of short-term use include memory and cognitive deficits, impaired motor coordination, and psychosis. Long-term use of THC has been associated to an increased risk of addiction, cognitive impairment, altered brain development when initial use was done early in adolescence, and an increased risk of chronic psychosis disorder including schizophrenia. The protective role that CBD could play to alleviate these negative effects is now well established and documented (Iseger and Bossong, 2015).

Terpenes

Terpenes form the largest group of phytochemicals, with more than 100 molecules identified in Cannabis (Rothschild et al., 2005; Brenneisen, 2007). Terpenes are responsible for the odor and flavor of the different Cannabis strains. They have therefore likely contributed to the selection of Cannabis narcotic strains under human domestication (Small, 2015). Terpenes are classified in diverse families according to the number of repeating units of 5-carbon building blocks (isoprene units), such as monoterpenes with 10 carbons, sesquiterpenes with 15 carbons, and triterpenes derived from a 30-carbon skeleton. Terpene yield and distribution in the plant vary according to numerous parameters, such as processes for obtaining essential oil, environmental conditions, or maturity of the plant (Meier and Mediavilla, 1998; Brenneisen, 2007). Mono- and sesquiterpenes have been detected in flowers, roots, and leaves of Cannabis, with the secretory glandular hairs as main production site. Monoterpenes dominate generally the volatile terpene profile (from 3.1 to 28.3 mg g-1 of flower dry weight, Fischedick et al., 2010) and include mainly D-limonene, β-myrcene, α- and β-pinene, terpinolene and linalool. Sesquiterpenes, and β-caryophyllene and α- humulene in particular, occur also to a large extent in Cannabis extracts (from 0.5 to 10.1 mg g-1 of flower dry weight, Fischedick et al., 2010). Triterpenes have also been detected in hemp roots, as friedelin and epifriedelanol (Slatkin et al., 1971), in hemp fibers as β-amyrin (Gutiérrez and del Río, 2005) and in hempseed oil as cycloartenol, β-amyrin, and dammaradienol (Paz et al., 2014).

Terpenes, along with cannabinoids, have successfully been used as chemotaxonomic markers in Cannabis, as they are both considered as the main physiologically active secondary metabolites (Fischedick et al., 2010; Elzinga et al., 2015). When grown in standardized conditions, a significant and positive correlation was found between the level of terpenes and cannabinoids (Fischedick et al., 2010). This may be explained by the fact that mono- and sesquiterpenes are synthesized in the same glandular trichomes in which the cannabinoids are produced (Meier and Mediavilla, 1998). This association was, however, not confirmed on a larger panel of samples coming from different origins (Elzinga et al., 2015).

Biosynthetic Pathways Leading to the Different Classes of Terpenes

Two different biosynthetic pathways contribute, in their early steps, to the synthesis of plant-derived terpenes (Figure 2). Whereas the cytosolic mevalonic acid (MVA) pathway is involved in the biosynthesis of sesqui-, and tri-terpenes, the plastid-localized MEP pathway contributes to the synthesis of mono-, di-, and tetraterpenes (Bouvier et al., 2005). MVA and MEP are produced through various and distinct steps, from two molecules of acetyl-coenzyme A and from pyruvate and D-glyceraldehyde-3-phosphate, respectively. They are further converted to isopentenyl diphosphate (IPP) and isomerised to dimethylallyl diphosphate (DMAPP), the end point of the MVA and MEP pathways. In the cytosol, two molecules of IPP (C5) and one molecule of DMAPP (C5) are condensed to produce farnesyl diphosphate (FPP, C15) by farnesyl diphosphate synthase (FPS). FPP serves as a precursor for sesquiterpenes (C15), which are formed by terpene synthases and can be decorated by other various enzymes. Two FPP molecules are condensed by squalene synthase (SQS) at the endoplasmic reticulum to produce squalene (C30), the precursor for triterpenes and sterols, which are generated by oxidosqualene cyclases (OSC) and are modified by various tailoring enzymes. In the plastid, one molecule of IPP and one molecule of DMAPP are condensed to form GPP (C10) by GPP synthase (GPS). GPP is the immediate precursor for monoterpenes (Kempinski et al., 2015).

Health Benefits Associated with Terpenes

Terpenes are lipophilic compounds that easily cross membranes and the blood-brain barrier in particular (Fukumoto et al., 2006). They present a wide-array of pharmacological properties, which have recently been described in several reviews (Russo, 2011; Singh and Sharma, 2015). The biological activities of D-limonene, also commonly found in Citrus essential oils, have been well described in the literature. It notably exhibits potent anti-cancer, anxiolytic and immunostimulating properties in humans (Komori et al., 1995). β-myrcene, a terpene commonly found in hop, is recognized as a potent anti-inflammatory, analgesic, and anxiolytic component (Cleemput et al., 2009). α-Pinene is an acetylcholinesteral inhibitor, and may thereby aid memory abilities (Kennedy et al., 2011), which could counteract the memory deficits induced by THC. Linalool, commonly found in Lavandula angustifolia, possesses similar properties to the ones described for its monoterpene counterparts, i.e., analgesic, anti-anxiety, anti-inflammatory, and anticonvulsant (Russo, 2011). β-caryophyllene, a well-known active principle of black pepper and Copaiba balsam, possesses potent anti-inflammatory and gastric cytoprotector activities (Singh and Sharma, 2015). Interestingly, it selectively binds to the CB2 receptor and could therefore technically be considered as a phytocannabinoid (Gertsch et al., 2008). Pentacyclic triterpenes such as β-amyrin and cycloartenol have been shown to possess numerous biological activities including anti-bacterial, anti-fungal, anti-inflammatory and anti-cancer properties (Vázquez et al., 2012; Moses et al., 2013). These triterpenes are key contributors to the pharmacological properties of numerous medicinal herbs (Kirby et al., 2008; Yadav et al., 2010; Sawai and Saito, 2011).

Phenolic Compounds

Phenolic compounds, also known as phenylpropanoids, constitute one of the most widely distributed group of secondary metabolites in the plant kingdom. They present more than 10,000 different structures, including phenolic acids, such benzoic and hydroxycinnamic acids, flavonoids such as flavonols and flavones, stilbenes and lignans (Andre et al., 2010). In Cannabis, about 20 flavonoids have been identified, mainly belonging to the flavone and flavonol subclasses (Flores-Sanchez and Verpoorte, 2008). These include the O-glycoside versions of the aglycones apigenin, luteolin, kaempferol and quercetin, as well as cannflavin A and cannflavin B, which are methylated isoprenoid flavones that are unique to Cannabis (Figure 2) (Ross et al., 2005). Phenolic amides and lignanamides have also been described in Cannabis fruits and roots (Sakakibara et al., 1992; Lesma et al., 2014). The lignanamides belong to the lignan class of compounds and include cannabisin-like compounds (of the types A-, B-, C-, D-, E-, F-, and G) and grossamide (Flores-Sanchez and Verpoorte, 2008). Similar compounds such as cannabisin D, have been described in Cannabis leaves, where it was strongly induced upon the UV-C treatment (Marti et al., 2014). Interesting amounts of lignans were recently found in the hydrophilic extract of hemp seeds. The hemp seed lignan profile was shown to be dominated by syringaresinol and medioresinol, followed by secoisolariciresinol, lariciresinol, and pinoresinol (Smeds et al., 2012). Hemp seeds contain, however, about 20-times less total lignans (32 mg of total lignans per 100 g of dry weight) than flax seeds, a well-known source of lignans. Interestingly, the lignan content of hulled hemp seeds represents only 1% of the content in whole seed (Smeds et al., 2012). Nineteen stilbenes have been isolated in Cannabis with characteristic structural backbones such as spirans, phenanthrenes and bibenzyls (Flores-Sanchez and Verpoorte, 2008). They include molecules such as cannabistilbene I, IIa and IIb, as well as dihydroresveratrol. Interestingly, bibenzyl stilbenes, including the putative 3-O-methylbatatasin, were strongly induced in Cannabis leaves by UV radiations (Marti et al., 2014).

Biosynthetic Pathway Leading to the Different Classes of Phenolic Compounds

Phenolic compounds are produced through the phenylpropanoid pathway in the cytoplasm and are subsequently transported in the vacuole or deposited in the cell wall (Figure 2). Routes to the major classes of phenolic compounds involve (i) the core phenylpropanoid pathway from phenylalanine to an activated (hydroxy) cinnamic acid derivative (p-coumaroyl CoA), via the actions of the phenylalanine-ammonia-lyase (PAL), cinnamate 4-hydroxylase (C4H, a cytochrome P450) and 4-coumarate-CoA ligase (4CL), as well as specific branch pathways for the formation of (ii) simple esters, lignins and lignans, (iii) flavonoids, (iv) coumarins, and (v) stilbenes (Andre et al., 2009; Naoumika et al., 2010; Docimo et al., 2013) (Figure 2). Although the flavonoid pathway has been extensively studied in several plants, there is no specific data on the biosynthesis of flavonoids in Cannabis. Generally, lignans such as secoisolariciresinol are produced in planta by stereoselective coupling of coniferyl alcohol moieties, via two distinct dirigent proteins, giving rise to (+) or (-) pinoresinol. Each pinoresinol can then be further enantiospecifically reduced to lariciresinol and secoisolariciresinol (Dalisay et al., 2015). The key molecular events associated with the biosynthesis of lignanamides are still unknown. The structure of these molecules suggests, however, a condensation of the precursors tyramine and CoA-esters of coumaric, caffeic, and coniferic acid (Flores-Sanchez and Verpoorte, 2008), followed by an oxidative coupling reaction catalyzed by a dirigent protein, as described for lignans. The flavonoid pathway is initiated by condensation of p-coumaroyl CoA with three molecules of malonyl-CoA (Figure 2). Naringenin chalcone is rapidly isomerized by the enzyme chalcone isomerase (CHI) to form naringenin, the branch point of flavonols on one hand and flavones on the other one. Flavanone 3-hydroxylase (F3H) may subsequently hydroxylate naringenin to produce the dihydroflavonol, dihydrokaempferol, which can be further hydroxylated by flavonoid 3′ hydroxylase (F3′H) to form dihydroquercetin. Dihydrokaempferol and dihydroquercetin are substrates of flavonol synthase (FLS), which catalyzes the production of the flavonols kaempferol and quercetin, respectively. Naringenin may alternatively be converted to apigenin, by a reaction catalised by a flavone synthase (FNS). Apigenin can be further hydroxylated by a flavonoid 3′ hydroxylase (F3′H) to form luteolin which is likely the precursor of the diverse cannflavins (Flores-Sanchez and Verpoorte, 2008).

Health Benefits Associated with Phenolic Compounds

In plants, phenolic compounds may act as antioxidants under certain physiological conditions and, thereby, protect plants against oxidative stress. In humans, it was shown that there is a correlation between dietary phenolic compound intake and a reduced incidence of chronic diseases such as cancers, cardiovascular and neurodegenerative diseases (Arts and Hollman, 2005), but these positive health effects may not be entirely explained by the phenolic antioxidant properties, as they are poorly bioavailable. Phenolic compounds may induce the up-regulation of endogenous antioxidant enzymes in vivo, due to their ability to act as pro-oxidants and generate Reactive Oxygen Species (ROS) (Halliwell et al., 2005). They may also exert their action through non-specific protein binding interactions (Gertsch et al., 2010). The flavones and flavonols found in Cannabis exert a wide range of biological effects, including properties shared by terpenes and cannabinoids. They present anti-inflammatory, anti-cancer and neuro-protective properties as reviewed in (Andre et al., 2010). In addition, apigenin has been shown to possess anxiolytic (Murti et al., 2012) and oestrogenic properties (Wang and Kurzer, 1998). The specific cannflavin A et B are potent anti-inflammatory compounds, via inhibition of prostaglandin E2 and 5-lipoxygenase (Werz et al., 2014). Health-related studies concerning lignanamides are scarce and showed in vitro anti-inflammatory (Sun et al., 2014) and cytotoxic activities (Cui-Ying et al., 2002). Lignans in general show a wide array of health-promoting properties including antioxidant, antiviral, antidiabetic, antitumorigenic and anti-obesity activities. Interestingly, secoisolariciresinol, lariciresinol and pinoresinol are converted into enterolignans by the anaerobic intestinal microflora, which are mammalian oestrogen precursors (phyto-oestrogens) (Wang et al., 2010). Due to the structural similarity of enterolignans with mammalian oestrogens, these compounds are potentially interesting for combating some hormone-dependent cancers. The mechanisms of action of the lignans are, however, complex, with multiple targets involved (Sainvitu et al., 2012).

Synergistic and Antagonistic Effects Between Phytochemicals

It is now well accepted that the health benefits of fruits, vegetables and other plant foods are due to the synergy or interactions between the different bioactive compounds or other nutrients present in the whole foods, and not to the action of a sole compound (Liu, 2013). Similarly, Cannabis-based therapeutics exert their pharmacological effects in humans via synergistic or antagonistic interactions between the various phytochemicals described above. These interactions may occur through various mechanisms including: (i) bioavailability, (ii) interference with cellular transport processes, (iii) activation of pro-drugs or deactivation of active compounds to inactive metabolites, (iv) action of synergistic partners at different points of the same signaling cascade (multi-target effects) or (v) inhibition of binding to target proteins (Efferth and Koch, 2011). A good example is the stronger muscle-antispastic effect of a Cannabis extract compared to pure THC, which represents an important finding for the treatment of multiple sclerosis (Wagner and Ulrich-Merzenich, 2009). Non-THC cannabinoids have shown positive influence on the side effects induced by THC such as anti-anxiety activities. CBD may also reduce the induced cognitive and memory deficits in subjects smoking Cannabis (Wright et al., 2013). CBD affects the pharmacokinetics of THC through different mechanisms: (i) by fluidizing the membranes and therefore increasing the penetration of THC in muscle cells, and (ii) by inhibiting the P450-mediated hepatic drug metabolism, which is involved in the degradation and elimination of the molecule (Klein et al., 2011). Terpenes may also alter the pharmacokinetics of THC by increasing the blood-brain barrier permeability. This characteristic has notably been used to patent a transdermal patch, which delivers cannabinoids into the bloodstream by using a terpene as a permeation agent (Smith, 2015). Terpenes may also modulate the affinity of THC for the CB1 receptor and interact with neurotransmitter receptors, which may support contributions of terpenes on cannabinoid-mediated analgesic and psychotic effects (McPartland and Russo, 2001; Russo, 2011). In view of the potential of phytocannabinoid-terpene synergy, it has been suggested to tailor novel therapeutic treatments such as CBD-terpene extracts to be used against acne, MRSA, depression, anxiety, insomnia, dementia and addiction (Russo, 2011).

Flavonoids may also modulate the pharmacokinetic of THC, via inhibition of the hepatic P450 enzymes (3A11 and 3A4) (McPartland and Russo, 2001; Russo, 2011).

Finally, there is an example of predator-targeted synergy between terpenes and phytocannabinoids in the Cannabis plant itself: on one side, the specific mixture of monoterpenes and sesquiterpenes determines viscosity and thereby the stickiness of Cannabis exudations necessary to trap the insects, and on the other one, the phytocannabinoid acid acts as potent insecticidal molecules (Sirikantaramas et al., 2005; Russo, 2011).

Cannabis Trichomes: Small Factories of Phytochemicals

Trichomes are epidermal protuberances covering the leaves, bracts and stems of plants and some of them, like the glandular trichomes, are capable of secreting (or storing) secondary metabolites as a defense mechanism. Several papers have focused on the characterization of these specialized structures using -omics (Wang et al., 2009a; Schilmiller et al., 2010; McDowell et al., 2011; Jin et al., 2014), because their integrated study can favor the development of technologies harnessing their rich biochemical potential (Schilmiller et al., 2008). An -omics database (TrichOME; available at: http://www.planttrichome.org/) enabling comparative analyses in plant trichomes has also been created with the purpose of providing the researchers with the possibility to mine data relative to metabolites, genes, expression profiles (Dai et al., 2010). Additionally, several procedures (in some instances supported by a video demonstration; e.g., Nayidu et al., 2014) for the isolation of trichomes from the leaves of different plant species are available (e.g., Marks et al., 2008; Balcke et al., 2014).

Hemp has different types of trichomes (Figures 3A–F) which belong to two categories, i.e., glandular and non-glandular (Happyana et al., 2013). Capitate sessile, capitate stalked and bulbous hemp trichomes are secretory structures (Figures 3C–F).

FIGURE 3
www.frontiersin.org

FIGURE 3. Hemp trichome types. (A) Unicellular non-glandular trichome; (B) cystolythic trichomes; (C) capitate sessile trichome; (D) capitate-stalked trichome; (E) simple bulbous trichome; (F) complex bulbous trichome. Images kindly provided by Dr. David J. Potter.

In Cannabis THCA is accumulated in the heads (glands) of both capitate-stalked and capitate sessile trichomes, but in the former the content is higher (Mahlberg and Kim, 2004). Notably, in the textile variety, the cannabinoids CBDA and CBCA occur at high concentrations instead of THCA, while the reverse is true for drug strains (Mahlberg and Kim, 2004).

Studies on hemp have demonstrated that THCA is synthesized in the storage cavity and that the enzyme responsible for THCA production, i.e., THCAS, follows a sorting pathway from the secretory cells to the storage cavity (Sirikantaramas et al., 2005). The accumulation in the storage cavity is due to the cytotoxicity of cannabinoids: they induce indeed death via apoptosis, when supplied for 24 h to both hemp and tobacco cell suspension cultures (Sirikantaramas et al., 2005). Heterologous expression of THCAS fused to GFP in tobacco leads to fluorescence of the trichome heads, thereby confirming the localization of the enzyme in the storage cavity (Sirikantaramas et al., 2005).

Depending on their color, hemp glandular trichomes show different secretory phases (Mahlberg and Kim, 2004): the mature secreting gland appears translucent (at this stage the cannabinoid content is the highest), while aging glands are yellow and senescing brown.

According to the current model cannabinoids are produced via terpenes secreted by plastids present in the disk cells and phenols stored in their vacuole (Mahlberg and Kim, 2004): analyses using the electron microscope have shown that oily secretions (most likely terpenes) round in shape are secreted from the plastids (which have the appearance of reticulate bodies). Subsequently vesicles are released into the cavity together with fibrillar matrix originating from the cell walls of the disk cells. The fibrillar matrix is transported to the subcuticular cell wall and contributes to its thickening via yet unidentified mechanisms (Mahlberg and Kim, 2004).

Besides cannabinoids, Cannabis trichomes produce other secondary metabolites, namely terpenes (see previous paragraph on Cannabis phytochemicals), which are responsible for the typical plant aroma (Russo, 2011). Among the Cannabis terpenes of low abundance, is nerolidol (0.09% of the total terpene content, Ross and ElSohly, 1996), which, interestingly, has anti-malarial and anti-leishmanial effects (reviewed by Russo, 2011). Given the pharmacological importance of these compounds, it would be interesting to devise engineering strategies aiming at either boosting the secondary metabolism, or increasing the density of trichomes in Cannabis. Among the possible genetic engineering approaches, it is here worth mentioning two examples recently reported in Artemisia annua. We will here discuss only these two examples, as further discussion on how to scale up the production of cannabinoids is presented later in this review.

It has been recently shown that the transformation of A. annua with the rolB and rolC genes of Agrobacterium rhizogenes led to plants with an increased content of artemisinin (Dilshad et al., 2015). The rol genes are known for their stimulatory action on plant secondary metabolism (Bulgakov, 2008). The study on A. annua showed that rolB and rolC trigger different effects, with rolB showing enhanced production with respect to rolC. An additional study on A. annua has shown that the expression of a β-glucosidase from Trichoderma reesei increases glandular trichome density and artemisinin production (Singh et al., 2015). The hydrolytic enzyme favors the release of active plant growth regulators from the conjugates stored in the plastids, thereby favoring trichome formation, as well as biomass production and leaf area (Singh et al., 2015). It would be interesting to devise an engineering strategy aimed at increasing the density of trichomes in Cannabis, by adopting a similar strategy. –Omics studies on Cannabis trichomes will help identify important genes, among which transcription factors (involved in trichome formation), which can be likewise used for engineering approaches.

Cannabis Biotechnology: Challenges and Prospects

Cannabis is a precious plant with multiple applications, hence the possibility of engineering it genetically to produce useful compounds/raw products is highly valuable. In this section of the review we will: (i) discuss the progress made in Cannabis in vitro propagation together with the biotechnological prospects of Cannabis genetic engineering, by highlighting the challenges and benefits, (ii) describe the hairy root culture system as a tool for the scalable production of cannabinoids and (iii) discuss the advantages of the Cannabis cell suspension culture system.

Cannabis In Vitro Propagation and Transformation

The cultivation of Cannabis is severely regulated in many countries; therefore alternative in vitro growth techniques are receiving a lot of attention. The in vitro cultivation of Cannabis is also an advantageous way to preserve cultivars/clones (Lata et al., 2009a) with specific metabolite signatures.

Methods to multiply C. sativa plants in vitro via stimulation of axillary buds on nodal segments, or induction of adventitious buds in the shoot tips have been described (Lata et al., 2009a; Wang et al., 2009b). It was shown that micro-propagated plants are genetically stable; therefore the method is appropriate and useful for the clonal multiplication of this important crop (Lata et al., 2010).

A protocol has also been developed for the propagation of hemp via the synthetic seed technology. According to this procedure, axillary buds or nodal segments are encapsulated in calcium alginate beads (Lata et al., 2009b, 2011), which can then be stored and subsequently used for clonal propagation of the plant. This system was shown to allow the successful growth of homogeneous and genetically stable Cannabis plants even after 6 months of storage (Lata et al., 2011).

To set up a successful Cannabis transformation protocol, the mastery of in vitro culture techniques is necessary: whether the strategy adopts plant explants or undifferentiated calli as starting material, the regeneration of the whole plant is a mandatory step. Organ regeneration, in particular shoots, can be quite cumbersome and therefore the screening of different plant growth regulator concentrations and combinations has to be carried out to find the right culture medium composition.

Cannabis sativa is a notorious recalcitrant plant to transformation, because the regeneration efficiencies are quite low and dependent upon the cultivar, tissue, plant age and growth regulator combination (Slusarkiewicz-Jarzina et al., 2005). As an example, although successful transformation of hemp calli via Agrobacterium tumefaciens was reported by Feeney and Punja (2003), the undifferentiated cells failed to regenerate the shoots. The cells were transformed with phosphomannose isomerase and colorimetric assays showed successful expression of the transgene.

Nevertheless some success in hemp regeneration was reported and shown to be linked to the choice of specific plant growth regulators. For example the addition of thidiazuron (TDZ), which has cytokinin-like activity, was shown to increase the development of shoots in hemp explants (Lata et al., 2009a) and in leaf-derived calli of a high yielding THCA clone (Lata et al., 2010). The herbicide DICAMBA was also reported to favor the regeneration of hemp shoots from calli (Slusarkiewicz-Jarzina et al., 2005).

Cannabis transformation protocols using plant explants (thereby avoiding the passage to undifferentiated cells) have been described for several important crops (e.g., cotton, Zapata et al., 1999; jute, Saha et al., 2014). Notably, successful transformation of hemp plants was reported by MacKinnon et al. (2001) using shoot tips: the protocol uses shoot tip explants and the regeneration potential of the shoot apical meristem after infection with A. tumefaciens. Additionally a patent application was filed describing Cannabis transformation using 1–2 cm hypocotyl explants, the plant growth regulators zeatin and 6-benzylaminopurine (BAP) for shoot regeneration (Sirkowski, 2012).

Hairy Root Cultures for the Production of Cannabinoids

An additional system offering interesting applications for the industrial production of compounds showing pharmaceutical effects in humans is the hairy root system, a type of Agrobacterium-transformed plant tissue culture used to study plant metabolic processes. Transformation of hemp and subsequent establishment of hairy root culture has been described by Wahby et al. (2013) using both A. rhizogenes and A. tumefaciens. In this study hypocotyls were found to be the most responsive tissue for infection. The hairy root system is very interesting for the production of secondary metabolites in medicinal plants (Jiao et al., 2014; Patra and Srivastava, 2014; Wawrosch et al., 2014; Gai et al., 2015; Tian, 2015) or to engineer model plants to secrete industrially valuable metabolites. For example, in tobacco transgenic hairy roots the production of THCA was successfully obtained by expressing hemp THCAS (Sirikantaramas et al., 2007). The hairy root system is characterized by hormone-independent high growth rate and by the same metabolic potential as the original organ (Pistelli et al., 2010). A protocol for the establishment of hairy roots from Cannabis callus cultures has also been described (Farag and Kayser, 2015). In this study calli were grown on full-strength B5 medium supplemented with 4 mg/L 1-Naphthaleneacetic acid (NAA) and their potential of cannabinoid production was evaluated. The authors found that after 28 days of cultivation in the dark, a peak could be observed in the accumulation of cannabinoids in culture media supplemented with different concentrations of indole-3-acetic acid (IAA). However, the yield remained below 2 μg/g of dry weight, thereby showing that further optimizations are still required in this field. The induction of rhizogenesis in undifferentiated Cannabis cells is important, because it can be performed on calli overexpressing key transcription factors and/or genes involved in the cannabinoid pathway.

The production of cannabinoids in hemp hairy root cultures can be then further implemented with adsorbents to avoid toxicity issues (a more detailed discussion concerning possible ways to avoid toxicity is present in the section dedicated to heterologous plant hosts). In alternative, inducible promoters can be used, like for instance the glucocorticoid-inducible promoter, which was already shown to be effective in inducing a controlled, reversible and dosage-dependent expression of GFP in Catharanthus roseus hairy roots (Hughes et al., 2002).

Cannabis Cell Suspension Cultures for the Production of Cannabinoids

Plant cell suspension cultures offer important advantages, as they can be transformed and then cultivated in bioreactors for the production of useful metabolites (Weathers et al., 2010; Bortesi et al., 2012; Liu et al., 2012; Han et al., 2014). Cannabis callus cultures are not able to produce any cannabinoids, irrespective of the chemotypes (drug-, hybrid-, or fiber-type) used as mother plants or growth regulators used in the culture medium (Pacifico et al., 2008). The transformation of hemp cell suspension cultures with genes involved in specific metabolic pathways can offer the possibility of enhancing the production of important classes of metabolites such as cannabinoids but also of others with potential pharmacological use. In this paragraph we will discuss about potential biotechnological approaches to boost the production of cannabinoids in Cannabis cell suspension culture.

The increased production of cannabinoids in Cannabis cell suspension cultures can be achieved via the expression of transcription factors involved in Cannabis gland biochemistry (Figure 4). Transcription factors represent a powerful tool in plant metabolic engineering, because of their “cascade” mechanism of action: if master regulators involved in cannabinoid biosynthesis are identified in C. sativa trichomes, they could be expressed constitutively or inducibly in Cannabis cell suspension cultures. It is important to mention here that two transcription factors belonging to the MYB family were already shown to be preferentially expressed in Cannabis glands (Marks et al., 2009) and therefore represent ideal candidates to express. These genes show homology with Arabidopsis thaliana MYB112 and MYB12, which are known to be involved in the tolerance to oxidative stress and flavonol biosynthesis, respectively (Marks et al., 2009 and references therein). The expression of these transcription factors in an inducible manner is a strategy worth being tested for the production of cannabinoids. The inducible expression will limit the negative effects caused by the toxicity of the accumulating cannabinoids during the growth of the transformed plant cells (as more thoroughly described in the next section).

FIGURE 4
www.frontiersin.org

FIGURE 4. Workflow showing the achievements (in green) and potential future approaches (in light blue) to produce cannabinoids in cultures of Cannabis, as well as other plant hosts.

In addition to the genetic engineering approach, plant cell suspension cultures can be elicited to boost the production of secondary metabolites. The literature is rich in examples concerning the increased expression of secondary metabolites in plant cells elicited with different factors (reviewed recently by Ncube and Van Staden, 2015). Both biotic and abiotic stress factors can indeed be used to re-direct the plant metabolism: nutrients, light, temperature, fungal elicitors are among the most common factors manipulated.

In hemp suspension cells, elicitation with biotic and abiotic elicitors did not induce an increase in cannabinoids (Flores-Sanchez et al., 2009); however, jasmonic acid was shown to elicit the production of the antioxidant tyrosol (Pec et al., 2010).

It is here worth mentioning the effect of a so far neglected element, silicon (Si). Despite being a non-essential element for plant growth, Si is known to increase plant vigor and to alleviate the effects of exogenous stresses (Epstein, 2009). Very recently Si was shown to alleviate the effects of salt stress and to induce the production of chlorogenic acid in Lonicera japonica (Gengmao et al., 2015). Given the stimulatory effects that Si has on plant metabolism, it is interesting to further investigate, from a molecular perspective, the effects of Si supplementation on Cannabis secondary metabolite production. Cyclodextrins have also been used in plant cell suspension cultures to enhance the production of various non-polar metabolites such as stilbenes (Yang et al., 2015), phytosterols (Sabater-Jara and Pedreño, 2013) or triterpenes (Goossens et al., 2015). Cyclodextrins are cyclic oligosaccharides consisting of five or more α-D-glucopyranose residues. They are known to form inclusion complexes with lipophilic compounds, including cannabinoids (Hazekamp and Verpoorte, 2006), in their hydrophobic cavity, thereby improving metabolite solubility in an aqueous environment. In addition, cyclodextrins, thanks to their chemical structure similar to that of the alkyl-derived oligosaccharides released from plant cell wall when a fungal infection occurs, act as elicitors of secondary metabolite production (Sabater-Jara and Pedreño, 2013).

It would therefore be worth investigating the effect of cyclodextrins on the production of the non-polar cannabinoids in hemp suspension cell cultures.

Cannabinoid Production in Heterologous Plant Hosts: How it can be Achieved and what Should be Taken into Account

The expression of genes involved in the cannabinoid biosynthetic pathway in cell suspension cultures of plants other than Cannabis represents an interesting alternative for the scalable production of cannabinoids (Figure 4). For example synthetic biology could be used to recreate the cannabinoid biosynthetic pathway in heterologous plant cells via the expression of THCAS, together with the upstream enzymes involved in the synthesis of CBG, i.e., the tetraketide synthase (the type III PKS), the aromatic prenyltransferase and the OAC (Gagne et al., 2012). In this respect tobacco bright yellow 2 (BY-2) cells are very interesting expression hosts, given their wide use in plant biotechnology as “workhorse” for the production of recombinant proteins (e.g., Reuter et al., 2014).

The biomimetic production of cannabinoids in heterologous plant hosts is challenging, however, one strategy that is worth taking into account concerns the use of synthetic “metabolons” (Singleton et al., 2014). A “metabolon” is the association of enzymes which carry out a series of sequential reactions in a given pathway. Examples for the occurrence of metabolons exist in plants for pathways involving, e.g., the synthesis of phenylpropanoids (Chen et al., 2014) and the cyanogenic glycoside dhurrin (Nielsen et al., 2008). Entire metabolic pathways can be engineered via the use of synthetic metabolons enabling the association of enzymes in close proximity: this allows a more efficient shunting of intermediates at the active site of enzymes acting in chain (Singleton et al., 2014). One possible way to assemble a synthetic metabolon is via the use of a scaffolding protein enabling the association of the enzymes (Singleton et al., 2014; Pröschel et al., 2015). In the specific case of cannabinoid production, the creation of a synthetic metabolon comprising for instance the type III PKS and OAC (Gagne et al., 2012), together with the aromatic prenyltransferase and the THCAS, can be achieved via (i) the use of dockerin-cohesin modules, or (ii) the metazoan signaling proteins SH3-, PDZ-, GBD binding domains, or (iii) the SpyTag/SpyCatcher domains (recently reviewed by Pröschel et al., 2015).

The assembly of multimodular constructs for expression in plants is no longer an insurmountable challenge, thanks to the development of methods like the Gateway-mediated cloning (reviewed by Dafny-Yelin and Tzfira, 2007), Golden Gate (Binder et al., 2014), GoldenBraid (Sarrion-Perdigones et al., 2011), to name a few.

When cannabinoids are produced in heterologous plant hosts, toxicity effects have to be taken into account, as it was shown that THCA and CBGA cause cell death via apoptosis in cells of Cannabis and tobacco BY-2 (Sirikantaramas et al., 2005). For plant cell suspension cultures cultivated in bioreactors, the in situ product removal via a two-phase culture system might be useful to favor the accumulation of the toxic metabolites produced in sites which are separated from the cells (Cai et al., 2012) (Figure 4). The use of adsorbents in the culture medium can not only sequester the toxic compounds, but also stimulate the secondary metabolite biosynthesis (Cai et al., 2012 and references therein).

One additional approach that can be used to avoid product toxicity in plant cell suspension cultures is artificial compartmentalization (Figure 4). This approach has been recently proposed in A. annua cell cultures for the production of artemisinin (Di Sansebastiano et al., 2015). The authors induced the formation of an artificial compartment (generated by membranes deriving from endocytosis and the endoplasmic reticulum-vacuole trafficking) via the expression of a truncated SNARE protein, AtSYP51. The creation of an artificial compartment can be used for the production of cannabinoids, because it can trap and stabilize the toxic secondary metabolites until extraction is performed, in a manner analogous to what discussed for artemisinin.

Perspectives and Conclusion

Hemp is a unique versatile plant, which can provide high biomass quantities in a short time. Hemp stem is used as a source of woody and bast fibers for the construction and automotive industries, while hemp seeds are used as a source of dietary oil and hemp leaves and flowers as a source of bioactive components.

To date, more than 540 phytochemicals have been described in hemp (Gould, 2015), and their pharmacological properties appear to go much beyond psychotic effects, with the capacity to address needs like the relief of chemotherapy-derived nausea and anorexia, and symptomatic mitigation of multiple sclerosis.

Continuously discovering new prototypes of drugs is of tremendous importance to meet tomorrow’s challenges in terms of public health (Atanasov et al., 2015). Nature has already provided a large source of new molecules and new skeletons. A recent review reporting the new drugs available on the market during the last 30 years showed that more than 35% of these new drugs have a direct natural origin. This percentage rises to over 60% if we take into account all the drugs whose structure is inspired by a natural pharmacophore (Newman and Cragg, 2012). Cannabis presents a colossal potential for enlarging the library of bioactive metabolites. Compounds can be obtained from hemp trichomes, cell suspension cultures, hairy root systems, or via the biotransformation of THCA or CBDA using fungal, bacterial, or plant cells (Akhtar et al., 2015).

Our increasing knowledge on the key molecular components triggering the diverse phytochemical pathways in planta (Figure 2), may also allow, through a genetic engineering approach, to further increase the production of specific cannabinoids, terpenes, or phenolic compounds, or to reconstruct the pathway in heterologous systems using a synthetic biology approach. Apart from the importance of studies focused on improving Cannabis genetic transformation, it is necessary to know more about the regulatory mechanisms involved in secondary metabolite production in C. sativa. For example enzymological and structural studies will help devise protein engineering approaches to improve the catalytic functions of key enzymes (Taura et al., 2007a). However, further studies would still be needed to elucidate other key genes involved in biosynthetic pathways of, for instance, less-abundant cannabinoid derivatives. For that purpose, the combination of metabolomics with genome-based functional characterizations of gene products would provide an accelerated path to discovering novel biosynthetic pathways to specialized metabolites. Indeed, the functions of numerous genes have been identified and characterized through the correlation of gene expression and metabolite accumulation (Sumner et al., 2015). Classical approaches used focused on the spatial and temporal distribution of the targeted phytochemicals and on the plant transcriptome, as influenced by the developmental stage and environmental stresses. With respect to the resurgence of interest in Cannabis phytochemicals nowadays, the results of such studies will be soon available.

Author Contributions

CA was involved in the review writing, J-FH was involved in manuscript refinement, and GG initiated the idea of the review and was involved in the manuscript writing.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The authors wish to thank the support by the Fonds National de la Recherche, Luxembourg (Project CANCAN C13/SR/5774202). Laurent Solinhac is gratefully acknowledged for providing the longitudinal cross section image of hemp stem appearing in Figure 1. The authors are grateful to Dr David J. Potter (GW Pharmaceuticals Ltd, Salisbury, Wiltshire, UK) for providing the trichome pictures appearing in Figure 3.

References

Akhtar, M., Shaari, K., and Verpoorte, R. (2015). Biotransformation of Tetrahydrocannabinol. Phytochem. Rev. 1–14. doi: 10.1007/s11101-015-9438-9

CrossRef Full Text | Google Scholar

Andre, C. M., Larondelle, Y., and Evers, D. (2010). Dietary antioxidants and oxidative stress from a human and plant perspective: a review. Curr. Nutr. Food Sci. 6, 2–12. doi: 10.2174/157340110790909563

CrossRef Full Text | Google Scholar

Andre, C. M., Schafleitner, R., Legay, S., Lefèvre, I., Aliaga, C. A., and Nomberto, G. (2009). Gene expression changes related to the production of phenolic compounds in potato tubers grown under drought stress. Phytochemistry 70, 1107–1116. doi: 10.1016/j.phytochem.2009.07.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Appendino, G., Gibbons, S., Giana, A., Pagani, A., Grassi, G., and Stavri, M. (2008). Antibacterial cannabinoids from Cannabis sativa: a structure-activity study. J. Nat. Prod. 71, 1427–1430. doi: 10.1021/np8002673

PubMed Abstract | CrossRef Full Text | Google Scholar

Arts, I. C., and Hollman, P. C. (2005). Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81, 317–325.

Google Scholar

Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., and Uhrin, P. (2015). Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv. 33, 1582–1614. doi: 10.1016/j.biotechadv.2015.08.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Balcke, G. U., Bennewitz, S., Zabel, S., and Tissier, A. (2014). Isoprenoid and metabolite profiling of plant trichomes. Methods Mol. Biol. 1153, 189–202. doi: 10.1007/978-1-4939-0606-2_13

PubMed Abstract | CrossRef Full Text | Google Scholar

Bao, Q., Liu, H., Fu, K., Zhang, C., Wang, C., and Feng, Y. (2014). Hemp Bast Fiber Extract with Antibacterial Activity, Preparation Method and Application of Hemp Bast Fiber Extract. Patent publication number CN104018343A. Washington, DC: U.S. Patent and Trademark Office.

Binder, A., Lambert, J., Morbitzer, R., Popp, C., Ott, T., and Lahaye, T. (2014). A modular plasmid assembly kit for multigene expression, gene silencing and silencing rescue in plants. PLoS ONE 9:e88218. doi: 10.1371/journal.pone.0088218

PubMed Abstract | CrossRef Full Text | Google Scholar

Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., and Coppola, D. (2013). Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease. Biochem. Pharmacol. 85, 1306–1316. doi: 10.1016/j.bcp.2013.01.017

PubMed Abstract | CrossRef Full Text | Google Scholar

Bortesi, L., Rademacher, T., Schiermeyer, A., Schuster, F., Pezzotti, M., and Schillberg, S. (2012). Development of an optimized tetracycline-inducible expression system to increase the accumulation of interleukin-10 in tobacco BY-2 suspension cells. BMC Biotechnol. 12:40. doi: 10.1186/1472-6750-12-40

PubMed Abstract | CrossRef Full Text | Google Scholar

Bouloc, P., Allegret, S., and Arnaud, L. (2013). Hemp: Industrial Production and Uses. Wallingford, CT: CABI Publishing.

Google Scholar

Bouvier, F., Rahier, A., and Camara, B. (2005). Biogenesis, molecular regulation and function of plant isoprenoids. Progr. Lipid Res. 44, 357–429. doi: 10.1016/j.plipres.2005.09.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Brenneisen, R. (2007). “Chemistry and analysis of phytocannabinoids and other cannabis constituents,” in Marijuana and the Cannabinoids Forensic Science and Medicine, ed. M. ElSohly (New York, NY: Humana Press), 17–49. doi: 10.1007/978-1-59259-947-9_2

PubMed Abstract | CrossRef Full Text | Google Scholar

Bruci, Z., Papoutsis, I., Athanaselis, S., Nikolaou, P., Pazari, E., and Spiliopoulou, C. (2012). First systematic evaluation of the potency of Cannabis sativa plants grown in Albania. Forensic. Sci. Int. 222, 40–46. doi: 10.1016/j.forsciint.2012.04.032

PubMed Abstract | CrossRef Full Text | Google Scholar

Bulgakov, V. P. (2008). Functions of ROL genes in plant secondary metabolism. Biotechnol. Adv. 26, 318–324. doi: 10.1016/j.biotechadv.2008.03.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Burstein, S. (2015). Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorgan. Med. Chem. 23, 1377–1385. doi: 10.1016/j.bmc.2015.01.059

PubMed Abstract | CrossRef Full Text | Google Scholar

Cai, Z., Kastell. A., Knorr, D., and Smetanska, I. (2012). Exudation: an expanding technique for continuous production and release of secondary metabolites from plant cell suspension and hairy root cultures. Plant Cell Rep. 31, 461–477. doi: 10.1007/s00299-011-1165-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Cappelletto, P., Brizzi, M., Mongardini, F., Barberi, B., Sannibale, M., and Nenci, G. (2001). Italy-grown hemp: yield, composition and cannabinoid content. Indust. Crop Prod. 13, 101–113. doi: 10.1016/S0926-6690(00)00057-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Cassano, R., Trombino, S., Ferrarelli, T., Nicoletta, F. P., Mauro, M. V., and Giraldi, C. (2013). Hemp fiber (Cannabis sativa L.) derivatives with antibacterial and chelating properties. Cellulose 20, 547–557. doi: 10.1007/s10570-012-9804-3

CrossRef Full Text | Google Scholar

Chen, H. C., Song, J., Williams, C. M., Shuford, C. M., Liu, J., and Wang, J. P. (2014). Systems biology of lignin biosynthesis in Populus trichocarpa: heteromeric 4-coumaric acid:coenzyme A ligase protein complex formation, regulation, and numerical modeling. Plant Cell 26, 876–893. doi: 10.1105/tpc.113.119685

PubMed Abstract | CrossRef Full Text | Google Scholar

Cleemput, M. V., Cattoor, K., Bosscher, K. D., Haegeman, G., Keukeleire, D. D., and Heyerick, A. (2009). Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds. J. Nat. Prod. 72, 1220–1230. doi: 10.1021/np800740m

PubMed Abstract | CrossRef Full Text | Google Scholar

Cui-Ying, M., Wing Keung, L., and Chun-Tao, C. (2002). Lignanamides and nonalkaloidal components of Hyoscyamus niger seeds. J. Nat. Prod. 65, 206–209. doi: 10.1021/np010073b

PubMed Abstract | CrossRef Full Text | Google Scholar

Dafny-Yelin, M., and Tzfira, T. (2007). Delivery of multiple transgenes to plant cells. Plant Physiol. 145, 1118–1128. doi: 10.1104/pp.107.106104

PubMed Abstract | CrossRef Full Text | Google Scholar

Dai, X., Wang, G., Yang, D. S., Tang, Y., Broun, P., and Marks, M. D. (2010). TrichOME: a comparative omics database for plant trichomes. Plant Physiol. 152, 44–54. doi: 10.1104/pp.109.145813

PubMed Abstract | CrossRef Full Text | Google Scholar

Dalisay, D. S., Kim, K. W., Lee, C., Yang, H., Rebel, O., and Bowen, B. P. (2015). Dirigent protein-mediated lignan and cyanogenic glucoside formation in flax seed: integrated -omics and MALDI mass spectrometry imaging. J. Nat. Prod. 78, 1231–1242. doi: 10.1021/acs.jnatprod.5b00023

PubMed Abstract | CrossRef Full Text | Google Scholar

Davis, W. M., and Hatoum, N. S. (1983). Neurobehavioral actions of cannabichromene and interactions with delta9-tetrahydrocannabinol. Gen. Pharmacol. Vasc. Sys. 14, 247–252. doi: 10.1016/0306-3623(83)90004-6

CrossRef Full Text | Google Scholar

DeLong, G. T., Wolf, C. E., Poklis, A., and Lichtman, A. H. (2010). Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol. Drug Alcohol Depend. 112, 126–133. doi: 10.1016/j.drugalcdep.2010.05.019

PubMed Abstract | CrossRef Full Text | Google Scholar

De Petrocellis, L., Ligresti, A., Moriello, A. S., Allarà, M., Bisogno, T., and Petrosino, S. (2011). Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br. J. Pharmacol. 163, 1479–1494. doi: 10.1111/j.1476-5381.2010.01166.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Dilshad, E., Cusido, R. M., Palazon, J., Estrada, K. R., Bonfill, M., and Mirza, B. (2015). Enhanced artemisinin yield by expression of rol genes in Artemisia annua. Malar. J. 14:424. doi: 10.1186/s12936-015-0951-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Di Marzo, V., and Piscitelli, F. (2015). The endocannabinoid system and its modulation by Phytocannabinoids. Neurotherapeutics 12, 692–698. doi: 10.1007/s13311-015-0374-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Di Sansebastiano, G. P., Rizzello, F., Durante, M., Caretto, S., Nisi, R., and De Paolis, A. (2015). Subcellular compartmentalization in protoplasts from Artemisia annua cell cultures: engineering attempts using a modified SNARE protein. J. Biotechnol. 202, 146–152. doi: 10.1016/j.jbiotec.2014.11.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Docimo, T., Consonni, R., Coraggio, I., and Mattana, M. (2013). Early phenylpropanoid biosynthetic steps in Cannabis sativa: link between genes and metabolites. Int. J. Mol. Sci. 14:13626. doi: 10.3390/ijms140713626

PubMed Abstract | CrossRef Full Text | Google Scholar

Efferth, T., and Koch, E. (2011). Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Target. 12, 122–132. doi: 10.2174/138945011793591626

PubMed Abstract | CrossRef Full Text | Google Scholar

Eisohly, H. N., Turner, C. E., Clark, A. M., and Eisohly, M. A. (1982). Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds. J. Pharm. Sci. 71, 1319–1323. doi: 10.1002/jps.2600711204

PubMed Abstract | CrossRef Full Text | Google Scholar

ElSohly, M. A., and Slade, D. (2005). Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 78, 539–548. doi: 10.1016/j.lfs.2005.09.011

PubMed Abstract | CrossRef Full Text | Google Scholar

Elzinga, S., Fischedick, J., Podkolinski, R., and Raber, J. C. (2015). Cannabinoids and terpenes as chemotaxonomic markers in cannabis. Nat. Prod. Chem. Res. 3:81. doi: 10.4172/2329-6836.1000181

CrossRef Full Text | Google Scholar

Englund, A. M., Stone, J., and Morrison, P. D. (2012). Cannabis in the arm: what can we learn from intravenous cannabinoid studies? Curr. Pharmaceut. Des. 18, 4906–4914. doi: 10.2174/138161212802884618

PubMed Abstract | CrossRef Full Text | Google Scholar

Epstein, E. (2009). Silicon: its manifold roles in plants. Ann. Appl. Biol. 155, 155–160. doi: 10.1111/j.1744-7348.2009.00343.x

CrossRef Full Text | Google Scholar

Farag, S., and Kayser, O. (2015). Cannabinoids production by hairy root cultures of Cannabis sativa L. Am. J. Plant Sci. 6, 1874–1884. doi: 10.4236/ajps.2015.611188

CrossRef Full Text | Google Scholar

Feeney, M., and Punja, Z. K. (2003). Tissue culture and Agrobacterium-mediated transformation of hemp (Cannabis sativa L.). In Vitro Cell. Dev. Biol. Plant 39, 578–585. doi: 10.1079/IVP2003454

CrossRef Full Text

Fellermeier, M., and Zenk, M. H. (1998). Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol. FEBS Lett. 427, 283–285. doi: 10.1016/S0014-5793(98)00450-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Fischedick, J. T., Hazekamp, A., Erkelens, T., Choi, Y. H., and Verpoorte, R. (2010). Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry 71, 2058–2073. doi: 10.1016/j.phytochem.2010.10.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Flores-Sanchez, I. J., Pec, J., Fei, J., Choi, Y. H., Dusek, J., and Verpoorte, R. (2009). Elicitation studies in cell suspension cultures of Cannabis sativa L. J. Biotechnol. 143, 157–168. doi: 10.1016/j.jbiotec.2009.05.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Flores-Sanchez, I. J., and Verpoorte, R. (2008). Secondary metabolism in Cannabis. Phytochem. Rev. 7, 615–639. doi: 10.1007/s11101-008-9094-4

CrossRef Full Text | Google Scholar

Fukumoto, S., Sawasaki, E., Okuyama, S., Miyake, Y., and Yokogoshi, H. (2006). Flavor components of monoterpenes in citrus essential oils enhance the release of monoamines from rat brain slices. Nutr. Neurosci. 9, 73–80. doi: 10.1080/10284150600573660

PubMed Abstract | CrossRef Full Text | Google Scholar

Gagne, S. J., Stout, J. M., Liu, E., Boubakir, Z., Clark, S. M., and Page, J. E. (2012). Identification of olivetolic acid cyclase from Cannabis sativa reveals a unique catalytic route to plant polyketides. Proc. Natl. Acad. Sci. U.S.A. 109, 12811–12816. doi: 10.1073/pnas.1200330109

PubMed Abstract | CrossRef Full Text | Google Scholar

Gai, Q. Y., Jiao, J., Luo, M., Wie, Z. F., Zu, Y. G., and Ma, W. (2015). Establishment of hairy root cultures by Agrobacterium rhizogenes mediated transformation of Isatis tinctoria L. for the efficient production of flavonoids and evaluation of antioxidant activities. PLoS ONE 10:e0119022. doi: 10.1371/journal.pone.0119022

PubMed Abstract | CrossRef Full Text | Google Scholar

Gengmao, Z., Shihui, L., Xing, S., Yizhou, W., and Zipan, C. (2015). The role of silicon in physiology of the medicinal plant (Lonicera japonica L.) under salt stress. Sci. Rep. 5:12696. doi: 10.1038/srep12696

PubMed Abstract | CrossRef Full Text | Google Scholar

Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., and Xie, X.-Q. (2008). Beta-caryophyllene is a dietary cannabinoid. Proc. Natl. Acad. Sci. U.S.A. 105, 9099–9104. doi: 10.1073/pnas.0803601105

PubMed Abstract | CrossRef Full Text | Google Scholar

Gertsch, J., Pertwee, R. G., and Di Marzo, V. (2010). Phytocannabinoids beyond the Cannabis plant – do they exist? Br. J. Pharmacol. 160, 523–529. doi: 10.1111/j.1476-5381.2010.00745.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Giacoppo, S., Mandolino, G., Galuppo, M., Bramanti, P., and Mazzon, E. (2014). Cannabinoids: new promising agents in the treatment of neurological diseases. Molecules 19, 18781–18816. doi: 10.3390/molecules191118781

PubMed Abstract | CrossRef Full Text | Google Scholar

Goossens, A., Moses, T., Pollier, J., and Almagro Romero, L. (2015). Triterpenoids Sapogenin Production in Plant and Microbial Cultures, U.S. Patent No. 20,150,141,633. Washington, DC: U.S. Patent and Trademark Office.

Gould, J. (2015). The Cannabis crop. Nature 525, S2–S3. doi: 10.1038/519S2a

PubMed Abstract | CrossRef Full Text | Google Scholar

Gu, L. F. (2006). Surgical Sewing Free Zipper Made of Antibiotic Material Hemp Fiber. Patent publication number CN 2829641 Y. Washington, DC: U.S. Patent and Trademark Office.

Guerriero, G., Hausman, J. F., Strauss, J., Ertan, H., and Siddiqui, K. S. (2015). Destructuring plant biomass: focus on fungal and extremophilic cell wall hydrolases. Plant Sci. 234, 180–193. doi: 10.1016/j.plantsci.2015.02.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Guerriero, G., Hausman, J.-F., Strauss, J., Ertan, H. and Siddiqui, K. S. (2016). Lignocellulosic biomass: biosynthesis, degradation, and industrial utilization. Eng. Life Sci. 16, 1–16. doi: 10.1002/elsc.201400196

CrossRef Full Text | Google Scholar

Guerriero, G., Sergeant, K., and Hausman, J. F. (2013). Integrated -omics: a powerful approach to understanding the heterogeneous lignification of fibre crops. Int. J. Mol. Sci. 14, 10958–10978. doi: 10.3390/ijms140610958

PubMed Abstract | CrossRef Full Text | Google Scholar

Guerriero, G., Sergeant, K., Hausman, J. F. (2014). Wood biosynthesis and typologies: a molecular rhapsody. Tree Physiol. 34, 839–855. doi: 10.1093/treephys/tpu031

PubMed Abstract | CrossRef Full Text | Google Scholar

Gutiérrez, A., and del Río, J. C. (2005). Chemical characterization of pitch deposits produced in the manufacturing of high-quality paper pulps from hemp fibers. Bioresour. Technol. 96, 1445–1450. doi: 10.1016/j.biortech.2004.12.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Halliwell, B., Rafter, J., and Jenner, A. (2005). Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 81, 268–276.

Google Scholar

Han, J. Y., Wang, H. Y., and Choi, Y. E. (2014). Production of dammarenediol-II triterpene in a cell suspension culture of transgenic tobacco. Plant Cell Rep. 33, 225–233. doi: 10.1007/s00299-013-1523-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Hao, X. M., Yang, Y., An, L. X., Wang, J. M., and Han, L. (2014). Study on antibacterial mechanism of hemp fiber. Adv. Mat. Res. 887–888, 610–613. doi: 10.4028/www.scientific.net/AMR.887-888.610

CrossRef Full Text | Google Scholar

Happyana, N., Agnolet, S., Muntendam, R., Van Dam, A., Schneider, B., and Kayser, O. (2013). Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR. Phytochemistry 87, 51–59. doi: 10.1016/j.phytochem.2012.11.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Hazekamp, A., and Verpoorte, R. (2006). Structure elucidation of the tetrahydrocannabinol complex with randomly methylated β-cyclodextrin. Eur. J. Pharm. Sci. 29, 340–347. doi: 10.1016/j.ejps.2006.07.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Hill, A. J., Williams, C. M., Whalley, B. J., and Stephens, G. J. (2012). Phytocannabinoids as novel therapeutic agents in {CNS} disorders. Pharmacol. Therapeut. 133, 79–97. doi: 10.1016/j.pharmthera.2011.09.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Hughes, E. H., Hong, S. B., Shanks, J. V., San, K. Y., and Gibson, S. I. (2002). Characterization of an inducible promoter system in Catharanthus roseus hairy roots. Biotechnol. Prog. 18, 1183–1186. doi: 10.1021/bp025603o

PubMed Abstract | CrossRef Full Text | Google Scholar

Ibrahim, T. A. (2012). Chemical composition and biological activity of extracts from Salvia bicolor Desf. growing in Egypt. Molecules 17, 11315–11334. doi: 10.3390/molecules171011315

PubMed Abstract | CrossRef Full Text | Google Scholar

Iseger, T. A., and Bossong, M. G. (2015). A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophr. Res. 162, 153–161. doi: 10.1016/j.schres.2015.01.033

PubMed Abstract | CrossRef Full Text | Google Scholar

Jiao, J., Gai, Q. Y., Fu, Y. J., Ma, W., Peng, X., and Tan, S. N. (2014). Efficient production of isoflavonoids by Astragalus membranaceus hairy root cultures and evaluation of antioxidant activities of extracts. J. Agric. Food Chem. 62, 12649–12658. doi: 10.1021/jf503839m

PubMed Abstract | CrossRef Full Text | Google Scholar

Jin, J., Panicker, D., Wang, Q., Kim, M. J., Liu, J., and Yin, J. L. (2014). Next generation sequencing unravels the biosynthetic ability of spearmint (Mentha spicata) peltate glandular trichomes through comparative transcriptomics. BMC Plant Biol. 14:292. doi: 10.1186/s12870-014-0292-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Kempinski, C., Jiang, Z., Bell, S., and Chappell, J. (2015). Metabolic engineering of higher plants and algae for isoprenoid production. Adv. Biochem. Eng. Biotechnol. 148:161. doi: 10.1007/10_2014_290

PubMed Abstract | CrossRef Full Text | Google Scholar

Kennedy, D. O., Dodd, F. L., Robertson, B. C., Okello, E. J., Reay, J. L., and Scholey, A. B. (2011). Monoterpenoid extract of sage (Salvia lavandulaefolia) with cholinesterase inhibiting properties improves cognitive performance and mood in healthy adults. J. Psychopharmacol. 25, 1088–1100. doi: 10.1177/0269881110385594

PubMed Abstract | CrossRef Full Text | Google Scholar

Khan, B. A., Wang, J., Warner, P., and Wang, H. (2015). Antibacterial properties of hemp hurd powder against E. coli. J. Appl. Polym. Sci. 132:41588. doi: 10.1002/app.41588

CrossRef Full Text | Google Scholar

Khan, B., Warner, P., and Wang, H. (2014). Antibacterial properties of hemp and other natural fibre plants: a review. Bioresources 9, 3642–3659. doi: 10.15376/biores.9.2.3642-3659

CrossRef Full Text | Google Scholar

Kiprono, P. C., Kaberia, F., Keriko, J. M., and Karanja, J. N. (2000). The in vitro anti-fungal and anti-bacterial activities of beta-sitosterol from Senecio lyratus (Asteraceae). Z. Naturforsch. C 55, 485–488.

PubMed Abstract | Google Scholar

Kirby, J., Romanini, D. W., Paradise, E. M., and Keasling, J. D. (2008). Engineering triterpene production in Saccharomyces cerevisiae–β-amyrin synthase from Artemisia annua. FEBS J. 275, 1852–1859. doi: 10.1111/j.1742-4658.2008.06343.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., and Huynh, T. (2011). Cannabidiol potentiates D9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology 218, 443–457. doi: 10.1007/s00213-011-2342-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Komori, T., Fujiwara, R., Tanida, M., Nomura, J., and Yokoyama, M. M. (1995). Effects of citrus fragrance on immune function and depressive states. Neuroimmunology 2, 174–180. doi: 10.1159/000096889

PubMed Abstract | CrossRef Full Text | Google Scholar

Kortekaas, S., Soto, M., Vicent, T., Field, J. A., and Lettinga, G. (1995). Contribution of extractives to methanogenic toxicity of hemp black liquor. J. Ferm. Bioeng. 80, 383–388. doi: 10.1016/0922-338X(95)94208-9

CrossRef Full Text | Google Scholar

Lata, H., Chandra, S., Khan, I., and ElSohly, M. A. (2009a). Thidiazuron induced high frequency direct shoot organogenesis of Cannabis sativa L. In vitro Cell. Dev. Biol. Plant 45, 12–19. doi: 10.1007/s11627-008-9167-5

CrossRef Full Text | Google Scholar

Lata, H., Chandra, S., Khan, I. A., and Elsohly, M. A. (2009b). Propagation through alginate encapsulation of axillary buds of Cannabis sativa L. - an important medicinal plant. Physiol. Mol. Biol. Plants 15, 79–86. doi: 10.1007/s12298-009-0008-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Lata, H., Chandra, S., Khan, I. A., and Elsohly, M. A. (2010). High frequency plant regeneration from leaf derived callus of high Δ9-tetrahydrocannabinol yielding Cannabis sativa L. Planta Med. 76, 1629–1633. doi: 10.1055/s-0030-1249773

PubMed Abstract | CrossRef Full Text | Google Scholar

Lata, H., Chandra, S., Techen, N., Khan, I. A., and ElSohly, M. A. (2011). Molecular analysis of genetic fidelity in Cannabis sativa L. plants grown from synthetic (encapsulated) seeds following in vitro storage. Biotechnol. Lett. 33, 2503–2508. doi: 10.1007/s10529-011-0712-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Leizer, C., Ribnicky, D., Poulev, A., Dushenkov, S., and Raskin, I. (2000). The composition of hemp seed oil and its potential as an important source of nutrition. J. Nutraceutical. Funct. Med. Food 2, 35–54. doi: 10.1300/J133v02n04_04

CrossRef Full Text | Google Scholar

Lesma, G., Consonni, R., Gambaro, V., Remuzzi, C., Roda, G., and Silvani, A. (2014). Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content. Nat. Prod. Res. 28, 1801–1807. doi: 10.1080/14786419.2014.926354

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, R. H. (2013). Health-promoting components of fruits and vegetables in the diet. Adv. Nutr. Int. Rev. J. 4, 384S–392S. doi: 10.3945/an.112.003517

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, Y. K., Huang, L. F., Ho, S. L., Liao, C. Y., Liu, H. Y., and Lai, Y. H. (2012). Production of mouse granulocyte-macrophage colony-stimulating factor by gateway technology and transgenic rice cell culture. Biotechnol. Bioeng. 109, 1239–1247. doi: 10.1002/bit.24394

PubMed Abstract | CrossRef Full Text | Google Scholar

Lynch, M. E., and Ware, M. A. (2015). Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized controlled trials. J. Neuroimmune. Pharmacol. 10, 1–9. doi: 10.1007/s11481-015-9600-6

PubMed Abstract | CrossRef Full Text | Google Scholar

MacKinnon, L., McDougall, G., Azis, N., and Millam, S. (2001). “Progress towards transformation of fibre hemp,” in Annual Report of the Scottish Crop Research Institute 2000/2001, eds W. H. Macfarlane Smith and T. D. Heilbronn (Dundee: SCRI Invergowrie), 84–86.

Google Scholar

Mahlberg, P. G., and Kim, E. S. (2004). Accumulation of cannabinoids in the secretory cavity of Cannabis. J. Industr. Hemp 9, 15–36. doi: 10.1300/J237v09n01_04

CrossRef Full Text

Marks, M. D., Betancur, L., Gilding, E., Chen, F., Bauer, S., and Wenger, J. P. (2008). A new method for isolating large quantities of Arabidopsis trichomes for transcriptome, cell wall and other types of analyses. Plant J. 56, 483–492. doi: 10.1111/j.1365-313X.2008.03611.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Marks, M. D., Tian, L., Wenger, J. P., Omburo, S. N., Soto-Fuentes, W., He, J., et al. (2009). Identification of candidate genes affecting Delta9-tetrahydrocannabinol biosynthesis in Cannabis sativa. J. Exp. Bot. 13, 3715–3726. doi: 10.1093/jxb/erp210

PubMed Abstract | CrossRef Full Text

Marsh, G. (2003). Next step for automotive materials. Mater. Today 6, 36–43. doi: 10.1016/S1369-7021(03)00429-2

CrossRef Full Text | Google Scholar

Marti, G., Schnee, S., Andrey, Y., Simoes-Pires, C., Carrupt, P.-A., and Wolfender, J.-L. (2014). Study of leaf metabolome modifications induced by UV-C radiations in representative Vitis, Cissus and Cannabis species by LC-MS based metabolomics and antioxidant assays. Molecules 19, 14004–14021. doi: 10.3390/molecules190914004

PubMed Abstract | CrossRef Full Text | Google Scholar

McDowell, E. T., Kapteyn, J., Schmidt, A., Li, C., Kang, J. H., and Descour, A. (2011). Comparative functional genomic analysis of Solanum glandular trichome types. Plant Physiol. 155, 524–539. doi: 10.1104/pp.110.167114

PubMed Abstract | CrossRef Full Text | Google Scholar

McPartland, J. M., and Russo, E. B. (2001). Cannabis and Cannabis extracts: greater than the sum of their parts? J. Cannabis Therapeut. 1, 103–132. doi: 10.1300/J175v01n03_08

CrossRef Full Text | Google Scholar

Meier, C., and Mediavilla, V. (1998). Factors influencing the yield and the quality of hemp (Cannabis sativa L.) essential oil. J. Int. Hemp Assoc. 5, 16–20.

Google Scholar

Meijer, E. P. M., de Hammond, K. M., and Micheler, M. (2009). The inheritance of chemical phenotype in Cannabis sativa L. (III): variation in cannabichromene proportion. Euphytica 165, 293–311. doi: 10.1007/s10681-008-9787-1

CrossRef Full Text | Google Scholar

Moses, T., Pollier, J., Thevelein, J. M., and Goossens, A. (2013). Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro. New Phytol. 200, 27–43. doi: 10.1111/nph.12325

PubMed Abstract | CrossRef Full Text | Google Scholar

Murti, K., Panchal, M. A., Gajera, V., and Solanki, J. (2012). Pharmacological properties of Matricaria recutita: a review. Pharmcognosy 3, 348–351.

Google Scholar

Naoumika, M. A., Zhao, Q., Gallego-Giraldo, L., Dai, X., Zhao, P. X., and Dixon, R. A. (2010). Genome-wide analysis of phenylpropanoid defence pathways. Mol. Plant Pathol. 11, 829–846. doi: 10.1111/j.1364-3703.2010.00648.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Nayidu, N., Bonham-Smith, P., and Gruber, M. Y. (2014). Trichome isolation and integrity test from Brassica villosa and other species. Bio. Protocol. 4:e1361. doi: 10.1007/s11103-014-0201-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Ncube, B., and Van Staden, J. (2015). Tilting plant metabolism for improved metabolite biosynthesis and enhanced human benefit. Molecules 20, 12698–12731. doi: 10.3390/molecules200712698

PubMed Abstract | CrossRef Full Text | Google Scholar

Newman, D. J., and Cragg, G. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311–335. doi: 10.1021/np200906s

PubMed Abstract | CrossRef Full Text | Google Scholar

Nielsen, K. A., Tattersall, D. B., Jones, P. R., and Møller, B. L. (2008). Metabolon formation in dhurrin biosynthesis. Phytochemistry 69, 88–98. doi: 10.1016/j.phytochem.2007.06.033

PubMed Abstract | CrossRef Full Text | Google Scholar

Pacher, P., Bátkai, S., and Kunos, G. (2006). The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol. Rev. 58, 389–462. doi: 10.1124/pr.58.3.2

PubMed Abstract | CrossRef Full Text | Google Scholar

Pacifico, D., Miselli, F., Carboni, A., Moschella, A., and Mandolino, G. (2008). Time course of cannabinoid accumulation and chemotype development during the growth of Cannabis sativa L. Euphytica 160, 231–240. doi: 10.1007/s10681-007-9543-y

CrossRef Full Text | Google Scholar

Patra, N., and Srivastava, A. K. (2014). Enhanced production of artemisinin by hairy root cultivation of Artemisia annua in a modified stirred tank reactor. Appl. Biochem. Biotechnol. 174, 2209–2222. doi: 10.1007/s12010-014-1176-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Paz, S., Montserrat, M. A., and Fernandez-Arche, M. A. (2014). Hemp (Cannabis sativa L.) seed oil: analytical and phytochemical characterization of the unsaponifiable fraction. J. Agr. Food Chem. 62, 1105–1110. doi: 10.1021/jf404278q

PubMed Abstract | CrossRef Full Text | Google Scholar

Pec, J., Flores-Sanchez, I. J., Choi, Y. H., and Verpoorte, R. (2010). Metabolic analysis of elicited cell suspension cultures of Cannabis sativa L. by (1)H-NMR spectroscopy. Biotechnol. Lett. 32, 935–941. doi: 10.1007/s10529-010-0225-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Petrović, M., Debeljak,Ž, Kezić, N., and Džidara, P. (2015). Relationship between cannabinoids content and composition of fatty acids in hempseed oils. Food Chem. 170, 218–225. doi: 10.1016/j.foodchem.2014.08.039

PubMed Abstract | CrossRef Full Text | Google Scholar

Pistelli, L., Giovannini, A., Ruffoni, B., Bertoli, A., and Pistelli, L. (2010). Hairy root cultures for secondary metabolites production. Adv. Exp. Med. Biol. 698, 167–184. doi: 10.1007/978-1-4419-7347-4_13

CrossRef Full Text | Google Scholar

Potter, D. J. (2004). “Growth and Morphology of Medicinal Cannabis,” in The Medicinal Uses of Cannabis and Cannabinoids, eds G. W. Guy, B. A. Whittle, and P. J. Robson (London: Pharmaceutical Press), 17–54.

Google Scholar

Pröschel, M., Detsch, R., Boccaccini, A. R., and Sonnewald, U. (2015). Engineering of metabolic pathways by artificial enzyme channels. Front. Bioeng. Biotechnol. 3:168. doi: 10.3389/fbioe.2015.00168

PubMed Abstract | CrossRef Full Text | Google Scholar

Radwan, M. M., ElSohly, M. A., Slade, D., Ahmed, S. A., Khan, I. A., and Ross, S. A. (2009). Biologically active cannabinoids from high-potency Cannabis sativa. J. Nat. Prod. 72, 906–911. doi: 10.1021/np900067k

PubMed Abstract | CrossRef Full Text | Google Scholar

Reuter, L. J., Bailey, M. J., Joensuu, J. J., and Ritala, A. (2014). Scale-up of hydrophobin-assisted recombinant protein production in tobacco BY-2 suspension cells. Plant Biotechnol. J. 12, 402–410. doi: 10.1111/pbi.12147

PubMed Abstract | CrossRef Full Text | Google Scholar

Ross, S. A., and ElSohly, M. A. (1996). The volatile oil composition of fresh and air-dried buds of Cannabis sativa. J. Nat. Prod. 59, 49–51. doi: 10.1021/np960004a

PubMed Abstract | CrossRef Full Text | Google Scholar

Ross, S. A., ElSohly, M. A., Sultana, G. N. N., Mehmedic, Z., Hossain, C. F., and Chandra, S. (2005). Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochem. Anal. 16, 45–48. doi: 10.1002/pca.809

PubMed Abstract | CrossRef Full Text | Google Scholar

Ross, S. A., Mehmedic, Z., Murphy, T. P., and ElSohly, M. A. (2000). GC-MS analysis of the total Δ9-THC content of both drug- and fiber-type Cannabis seeds. J. Anal. Toxicol. 4, 715–717. doi: 10.1093/jat/24.8.715

CrossRef Full Text | Google Scholar

Rothschild, M., Bergstrom, G., and Wangberg, S. (2005). Cannabis sativa: volatile compounds from pollen and entire male and female plants of two variants, Northern Lights and Hawaian Indica. Bot. J. Linn. Soc. 147, 387–397. doi: 10.1111/j.1095-8339.2005.00417.x

CrossRef Full Text | Google Scholar

Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol. 163, 1344–1364. doi: 10.1111/j.1476-5381.2011.01238.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Russo, E. B., Jiang, H. E., Li, X., Sutton, A., Carboni, A., del Bianco, F., et al. (2008). Phytochemical and genetic analyses of ancient Cannabis from Central Asia. J. Exp. Bot. 59, 4171–4182. doi: 10.1093/jxb/ern260

PubMed Abstract | CrossRef Full Text | Google Scholar

Sabater-Jara, A. B., and Pedreño, M. A. (2013). Use of β-cyclodextrins to enhance phytosterol production in cell suspension cultures of carrot (Daucus carota L.). Plant Cell Tissue Organ Cult. 114, 249–258. doi: 10.1007/s11240-013-0320-4

CrossRef Full Text | Google Scholar

Saha, P., Datta, K., Majumder, S., Sarkar, C., China, S. P., and Sarkar, S. N. (2014). Agrobacterium mediated genetic transformation of commercial jute cultivar Corchorus capsularis cv. JRC 321 using shoot tip explants. Plant Cell Tiss. Organ. Cult. 118, 313–326. doi: 10.1007/s11240-014-0484-6

CrossRef Full Text | Google Scholar

Sainvitu, P., Nott, K., Richard, G., Blecker, C., Jérôme, C., Wathelet, J.-P., et al. (2012). Structure, properties and obtention routes of flaxseed lignan secoisolariciresinol. Biotechnol. Agron. Soc. 16, 115–124.

Google Scholar

Sakakibara, I., Ikeya, Y., Hayashi, K., and Mitsuhashi, H. (1992). Three phenyldihydronaphthalene lignanamides from fruits of Cannabis sativa. Phytochemistry 31, 3219–3223. doi: 10.1016/0031-9422(92)83479-I

PubMed Abstract | CrossRef Full Text | Google Scholar

Sarrion-Perdigones, A., Falconi, E. E., Zandalinas, S. I., Juárez, P., Fernández-del-Carmen, A., and Granell, A. (2011). GoldenBraid: an iterative cloning system for standardized assembly of reusable genetic modules. PLoS ONE 6:e21622. doi: 10.1371/journal.pone.0021622

PubMed Abstract | CrossRef Full Text | Google Scholar

Sawai, S., and Saito, K. (2011). Triterpenoid biosynthesis and engineering in plants. Front. Plant Sci. 2:25. doi: 10.3389/fpls.2011.00025

PubMed Abstract | CrossRef Full Text | Google Scholar

Schilmiller, A. L., Last, R. L., and Pichersky, E. (2008). Harnessing plant trichome biochemistry for the production of useful compounds. Plant J. 54, 702–711. doi: 10.1111/j.1365-313X.2008.03432.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Schilmiller, A. L., Miner, D. P., Larson, M., McDowell, E., Gang, D. R., and Wilkerson, C. (2010). Studies of a biochemical factory: tomato trichome deep expressed sequence tag sequencing and proteomics. Plant Physiol. 153, 1212–1223. doi: 10.1104/pp.110.157214

PubMed Abstract | CrossRef Full Text | Google Scholar

Singh, B., and Sharma, R. (2015). Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications. 3 Biotechnol. 5, 129–151. doi: 10.1007/s13205-014-0220-2

CrossRef Full Text | Google Scholar

Singh, N. D., Kumar, S., and Daniell, H. (2015). Expression of β-glucosidase increases trichome density and artemisinin content in transgenic Artemisia annua plants. Plant Biotechnol. J. doi: 10.1111/pbi.12476 [Epub ahead of print].

PubMed Abstract | CrossRef Full Text | Google Scholar

Singleton, C., Howard, T. P., and Smirnoff, N. (2014). Synthetic metabolons for metabolic engineering. J. Exp. Bot. 65, 1947–1954. doi: 10.1093/jxb/eru050

PubMed Abstract | CrossRef Full Text | Google Scholar

Sirikantaramas, S., Morimoto, S., Shoyama, Y., Ishikawa, Y., Wada, Y., and Shoyama, Y. (2004). The gene controlling marijuana psychoactivity: molecular cloning and heterologous expression of Δ1-tetrahydrocannabinolic acid synthase from Cannabis sativa L. J. Biol. Chem. 279, 39767–39774. doi: 10.1074/jbc.M403693200

PubMed Abstract | CrossRef Full Text | Google Scholar

Sirikantaramas, S., Taura, F., Morimoto, S., and Shoyama, Y. (2007). Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology. Curr. Pharm. Biotechnol. 8, 237–243. doi: 10.2174/138920107781387456

PubMed Abstract | CrossRef Full Text | Google Scholar

Sirikantaramas, S., Taura, F., Tanaka, Y., Ishikawa, Y., Morimoto, S., and Shoyama, Y. (2005). Tetrahydrocannabinolic acid synthase, the enzyme controlling marijuana psychoactivity, is secreted into the storage cavity of the glandular trichomes. Plant Cell Physiol. 46, 1578–1582. doi: 10.1093/pcp/pci166

PubMed Abstract | CrossRef Full Text | Google Scholar

Sirkowski, E. (2012). Marked Cannabis for indicating medical Marijuana. US Patent 20120311744.

Google Scholar

Skoglund, G., Nockert, M., and Holst, B. (2013). Viking and early Middle Ages northern Scandinavian textiles proven to be made with hemp. Sci. Rep. 3:2686. doi: 10.1038/srep02686

PubMed Abstract | CrossRef Full Text | Google Scholar

Slatkin, D. J., Doorenbos, N. J., Harris, L. S., Masoud, A. N., Quimby, M. W., and Schiff, P. L. (1971). Chemical constituents of Cannabis sativa L. Root. J. Pharmaceut. Sci. 60, 1891–1892. doi: 10.1002/jps.2600601232

PubMed Abstract | CrossRef Full Text | Google Scholar

Slusarkiewicz-Jarzina, A., Ponitka, A., and Kaczmarek, Z. (2005). Influence of cultivar, explant source and plant growth regulator on callus induction and plant regeneration of Cannabis sativa L. Acta Biol. Cracov. Ser. Bot. 47, 145–151.

Google Scholar

Small, E. (2015). Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Bot. Rev. 81, 189–294. doi: 10.1007/s12229-015-9157-3

CrossRef Full Text | Google Scholar

Smeds, A. I., Eklund, P. C., and William, S. M. (2012). Content, composition, and stereochemical characterisation of lignans in berries and seeds. Food Chem. 134, 1991–1998. doi: 10.1016/j.foodchem.2012.03.133

PubMed Abstract | CrossRef Full Text | Google Scholar

Smith, N. (2015). Transdermal Cannabinoid Patch, U.S. Patent No. 20,150,297,556. Washington, DC: U.S. Patent and Trademark Office.

Google Scholar

Stout, J. M., Boubakir, Z., Ambrose, S. J., Purves, R. W., and Page, J. E. (2012). The hexanoyl-CoA precursor for cannabinoid biosynthesis is formed by an acyl-activating enzyme in Cannabis sativa trichomes. Plant J. 71, 353–365. doi: 10.1111/j.1365-313X.2012.04949.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Sumner, L. W., Lei, Z., Nikolau, B. J., and Saito, K. (2015). Modern plant metabolomics: advanced natural product gene discoveries, improved technologies, and future prospects. Nat. Prod. Rep. 32, 212–229. doi: 10.1039/C4NP00072B

PubMed Abstract | CrossRef Full Text | Google Scholar

Sun, J., Gu, Y.-F., Su, X.-Q., Li, M.-M., Huo, H.-X., Zhang, J., et al. (2014). Anti-inflammatory lignanamides from the roots of Solanum melongena L. Fitoterapia 98, 110–116. doi: 10.1016/j.fitote.2014.07.012

PubMed Abstract | CrossRef Full Text | Google Scholar

Taura, F., Sirikantaramas, S., Shoyama, Y., Shoyama, Y., and Morimoto, S. (2007a). Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes. Chem. Biodiv. 4, 1649–1663. doi: 10.1002/cbdv.200790145

PubMed Abstract | CrossRef Full Text | Google Scholar

Taura, F., Dono, E., Sirikantaramas, S., Yoshimura, K., Shoyama, Y., and Morimoto, S. (2007b). Production of Delta(1)-tetrahydrocannabinolic acid by the biosynthetic enzyme secreted from transgenic Pichia pastoris. Biochem. Biophys. Res. Commun. 361, 675–680. doi: 10.1016/j.bbrc.2007.07.079

PubMed Abstract | CrossRef Full Text | Google Scholar

Tian, L. (2015). Using hairy roots for production of valuable plant secondary metabolites. Adv. Biochem. Eng. Biotechnol. 149, 275–324. doi: 10.1007/10_2014_298

PubMed Abstract | CrossRef Full Text | Google Scholar

van Amsterdam, J., Brunt, T., and van den Brink, W. (2015). The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. J. Psychopharmacol. 29, 254–263. doi: 10.1177/0269881114565142

PubMed Abstract | CrossRef Full Text | Google Scholar

van Bakel, H., Stout, J. M., Cote, A. G., Tallon, C. M., Sharpe, A. G., and Hughes, T. R. (2011). The draft genome and transcriptome of Cannabis sativa. Genome Biol. 12:R102. doi: 10.1186/gb-2011-12-10-r102

PubMed Abstract | CrossRef Full Text | Google Scholar

Vázquez, L. H., Palazon, J., and Navarro-Ocaña, A. (2012). The pentacyclic triterpenes α-, β-amyrins: a review of sources and biological activities. Phytochemicals 23, 487–502.

Google Scholar

Volkow, N. D., Baler, R. D., Compton, W. M., and Weiss, S. R. (2014). Adverse health effects of marijuana use. N. Engl. J. Med. 370, 2219–2227. doi: 10.1056/NEJMra1402309

PubMed Abstract | CrossRef Full Text | Google Scholar

Wagner, H., and Ulrich-Merzenich, G. (2009). Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 16, 97–110. doi: 10.1016/j.phymed.2008.12.018

PubMed Abstract | CrossRef Full Text | Google Scholar

Wahby, I., Caba, J. M., and Ligero, F. (2013). Agrobacterium infection of hemp (Cannabis sativa L.): establishment of hairy root cultures. J. Plant. Interact. 8, 312–320. doi: 10.1080/17429145.2012.746399

CrossRef Full Text | Google Scholar

Wang, C., and Kurzer, M. S. (1998). Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nut. Cancer 31, 90–100. doi: 10.1080/01635589809514686

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, C.-Z., Ma, X.-Q., Yang, D.-H., Guo, Z.-R., Liu, G.-R., Zhao, G.-X., et al. (2010). Production of enterodiol from defatted flaxseeds through biotransformation by human intestinal bacteria. BMC Microbiol. 10:115. doi: 10.1186/1471-2180-10-115

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, W., Wang, Y., Zhang, Q., Qi, Y., and Guo, D. (2009a). Global characterization of Artemisia annua glandular trichome transcriptome using 454 pyrosequencing. BMC Genomics 10:465. doi: 10.1186/1471-2164-10-465

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, R., He, L. S., Xia, B., Tong, J. F., Li, N., and Peng, F. (2009b). A micropropagation system for cloning of hemp (Cannabis sativa L.) by shoot tip culture. Pak. J. Bot. 41, 603–608.

Google Scholar

Wawrosch, C., Schwaiger, S., Stuppner, H., and Kopp, B. (2014). Lignan formation in hairy root cultures of Edelweiss (Leontopodium nivale ssp. alpinum (Cass.) Greuter). Fitoterapia 97, 219–223. doi: 10.1016/j.fitote.2014.06.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Weathers, P. J., Towler, M. J., and Xu, J. (2010). Bench to batch: advances in plant cell culture for producing useful products. Appl. Microbiol. Biotechnol. 85, 1339–13351. doi: 10.1007/s00253-009-2354-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Weiblen, G. D., Wenger, J. P., Craft, K. J., ElSohly, M. A., Mehmedic Z., Treiber, E. L., et al. (2015). Gene duplication and divergence affecting drug content in Cannabis sativa. New Phytol. 208, 1241–1250. doi: 10.1111/nph.13562

PubMed Abstract | CrossRef Full Text | Google Scholar

Werz, O., Seegers, J., Schaible, A. M., Weinigel, C., Barz, D., Koeberle, A., et al. (2014). Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin -E2 synthase-1 and 5-lipoxygenase. Pharmanutr 2, 53–60. doi: 10.1016/j.phanu.2014.05.001

CrossRef Full Text | Google Scholar

Wright, M. J., Vandewater, S. A., and Taffe, M. A. (2013). Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ(9)tetrahydrocannabinol. Br. J. Pharmacol. 170, 1365–1373. doi: 10.1111/bph.12199

PubMed Abstract | CrossRef Full Text | Google Scholar

Yadav, V. R., Prasad, S., Sung, B., Kannappan, R., and Aggarwal, B. B. (2010). Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins 2, 2428–2466. doi: 10.3390/toxins2102428

PubMed Abstract | CrossRef Full Text | Google Scholar

Yang, T., Fang, L., Nopo-Olazabal, C., Condori, J., Nopo-Olazabal, L., Balmaceda, C., et al. (2015). Enhanced Production of Resveratrol, Piceatannol, Arachidin-1, and Arachidin-3 in Hairy Root Cultures of Peanut Co-treated with Methyl Jasmonate and Cyclodextrin. J. Agric. Food Chem. 63, 3942–3950. doi: 10.1021/jf5050266

PubMed Abstract | CrossRef Full Text | Google Scholar

Zapata, C., Park, S. H., El-Zik, K. M., and Smith, R. H. (1999). Transformation of a Texas cotton cultivar by using Agrobacterium and the shoot apex. Theor. Appl. Genet. 98, 252–256. doi: 10.1007/s001220051065

CrossRef Full Text | Google Scholar

Zirpel, B., Stehle, F., and Kayser, O. (2015). Production of Δ9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing Δ9-tetrahydrocannabinolic acid synthase from Cannabis sativa L. Biotechnol. Lett. 37, 1869–1875. doi: 10.1007/s10529-015-1853-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: fibers, hemp, Cannabis, cellulose, lignin, cannabinoids, terpenes, lignans

Citation: Andre CM, Hausman J-F and Guerriero G (2016) Cannabis sativa: The Plant of the Thousand and One Molecules. Front. Plant Sci. 7:19. doi: 10.3389/fpls.2016.00019

Received: 27 October 2015; Accepted: 08 January 2016;
Published: 04 February 2016.

Edited by:

Eugenio Benvenuto, ENEA, Italian National Agency for New Technologies, Energy and Sustainable Economic Development, Italy

Reviewed by:

Biswapriya Biswavas Misra, University of Florida, USA
Felix Stehle, Technical University of Dortmund, Germany

Copyright © 2016 Andre, Hausman and Guerriero. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Christelle M. Andre, christelle.andre@list.lu